Biogen’s Alzheimer’s Drug Slows Mental Decline in Early Study

Biogen is entering a field littered with expensive failures from such drug makers as Pfizer Inc and Eli Lilly and Co. Lilly and Roche Holding AG are both conducting trials on drugs that work the same way as Biogen’s, by blocking beta amyloid, a protein that forms toxic brain plaques that are theoretically an underlying cause of the degenerative brain disease.

READ MORE

First Name

Last Name

Email address:

List choice Our House D.C. WIN Daily

Leave this field empty if you're human: